Thymidine-modulated 5-fluorouracil metabolism in liver and RIF-1 tumors studied by 19F magnetic resonance spectroscopy
- 31 December 1992
- journal article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 10 (3) , 385-392
- https://doi.org/10.1016/0730-725x(92)90509-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Multinuclear MR investigation of the metabolic response of the murine RIF‐1 tumor to 5‐fluorouracil chemotherapyMagnetic Resonance in Medicine, 1991
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988
- Schedule-dependent antitumor and toxic effects of thymidine and 5-fluorouracil in AKR and L1210 leukemiasCancer Chemotherapy and Pharmacology, 1986
- Shielded solenoidal probe for in Vivo NMR studies of solid tumorsMagnetic Resonance in Medicine, 1985
- 5-Flourouracil metabolism monitored in vivo by 19F NMRBritish Journal of Cancer, 1984
- An update on the biochemistry of 5-fluorouracilCancer Treatment Reviews, 1981
- Combination clinical trials with thymidine and fluorouracil: A phase I and clinical pharmacologic evaluationCancer, 1980
- Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU) RNACancer, 1980
- An overview of thymidineCancer, 1980
- Synthetic pyrimidines as inhibitors of uracil and thymine degradation by rat-liver supernatantBiochimica et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related Subjects, 1964